Epigenome Network of Excellence - http://www.epigenome-noe.net/index.php The Epigenome Network of Excellence (NoE) is a centre dedicated to bringing together 25 established research groups, 12 newly established research teams (NETs) and 26 associates, from 10 European countries, under a 12.5 M€ grant from the European Union (EU) Framework 6 Programme (FP6) to advance epigenetic research over the next 5 years (2004-2009). - [Read more]

Epigenomics AG - http://www.epigenomics.com/ Epigenomics AG, located in Berlin, Germany, is a transatlantic biotechnology company. It is subsides in Seattle, Washington, USA. Its main goals are to pioneer the futures medicine by unravelling the information behind patterns of DNA methylation. - [Read more]

Epigenomics DNA Methylation - http://www.epigenomics.com/pdf_temp/2_science-and-technologies.pdf Find information on DNA Methylation and Epigenomics. - [Read more]

Genomic DNA Methylation Analysis - http://www.appliedbiosystems.com/about/presskit/pdfs/dna_methylation_analysis.pdf Find information in this article on genomic sequencing and advances in DNA methylation analysis. - [Read more]

Human Epigenome Consortium - http://www.epigenome.org/ The Human Epigenome Consortium is a collaboration of public/private teams that have a unified goal to identify and catalogue all Methylation Variable Positions (MVPs) foudn within the human genome. - [Read more]

The Centre National de Génotypage - http://www.cng.fr/ The Centre National de Génotypage was setup in 1998 by the Government of France as a national research centre. Its goal is to use the sequencing information generated by the genome project for the identification of genes and gene function. - [Read more]

The Sanger Institute - http://www.sanger.ac.uk/ The Sanger Institute is an institute dedicated to genome research. It is primarily funded by the Wellcome Trust and its goal is to progress the knowledge of genomes. The Sanger Institute advances knowledge particularly through the use of large scale sequencing and analysis. - [Read more]